A Bayesian Method Based on Clotting Factor Activity for the Prediction of Maintenance Warfarin Dosage Regimens

A Bayesian algorithm, employing a population pharmacokinetic–pharmacodynamic model, for the effective and rapid prediction of warfarin maintenance dosing requirements was developed. The algorithm was evaluated prospectively in five healthy volunteers who were given a 15-mg single dose of racemic warfarin. Based on previous population pharmacokinetic and pharmacodynamic parameters and factor VII response measurements taken during the first 48 hours, dosage regimens to achieve a subtherapeutic degree of anticoagulation (50% of normal) were determined. Three factor VII response measurements were sufficient to determine dosing requirements in the five volunteers. The advantage of the algorithm is that it does not require warfarin concentration measurements and uses non–steady-state data.

[1]  M S Leaning,et al.  Validation of an algorithm for oral anticoagulant dosing and appointment scheduling. , 1995, Clinical and laboratory haematology.

[2]  E. Chan,et al.  Stereochemical aspects of warfarin drug interactions: Use of a combined pharmacokinetic‐pharmacodynamic model , 1994, Clinical pharmacology and therapeutics.

[3]  S. Doi,et al.  Pharmacodynamic optimization of warfarin therapy , 1994, Clinical pharmacology and therapeutics.

[4]  M. Grind,et al.  Method for studying drug‐warfarin interactions , 1993, Clinical pharmacology and therapeutics.

[5]  Malcolm Rowland,et al.  Population pharmacokinetics and pharmacodynamics of warfarin in healthy young adults , 1993 .

[6]  L. Poller,et al.  Prospective comparative study of computer programs used for management of warfarin. , 1993, Journal of clinical pathology.

[7]  M. Narayanan,et al.  A Genetic Algorithm to Improve a Neural Network to Predict a Patient’s Response to Warfarin , 1993, Methods of Information in Medicine.

[8]  H. Chrystyn,et al.  BAYESIAN DERIVED PHARMACOKINETIC/PHARMACODYNAMIC VARIABLES FROM WARFARIN THERAPY , 1990 .

[9]  G. Raskob,et al.  Predicting the Daily Prothrombin Time Response to Warfarin , 1990, Therapeutic drug monitoring.

[10]  L. Ovesen,et al.  A simple technique for predicting maintenance dosage of warfarin — Is it better than empirical dosing? , 1989, European Journal of Clinical Pharmacology.

[11]  D. Mungall,et al.  Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response. , 1987, Clinical pharmacy.

[12]  D. Mungall,et al.  Pharmacodynamics of Warfarin at Steady State , 1987, Therapeutic drug monitoring.

[13]  A. Breckenridge,et al.  Enantiomers of warfarin and vitamin K1 metabolism. , 1986, British journal of clinical pharmacology.

[14]  N. Holford.  Clinical Pharmacokinetics and Pharmacodynamics of Warfarin , 1986, Clinical pharmacokinetics.

[15]  Silvana,et al.  Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. , 1986, The Journal of clinical investigation.

[16]  M. Rowland,et al.  Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine. , 1984, Journal of pharmaceutical sciences.

[17]  L B Sheiner,et al.  Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. , 1982, Journal of pharmaceutical sciences.

[18]  T J O'Leary,et al.  Evaluation of a computer‐assisted method for individualized anticoagulation: Retrospective and prospective studies with a pharmacodynamic model , 1982, Clinical pharmacology and therapeutics.

[19]  R. O'Reilly.  Stereoselective Interaction of Sulfinpyrazone with Racemic Warfarin and Its Separated Enantiomorphs in Man , 1982, Circulation.

[20]  R. Bell,et al.  Inhibition by warfarin enantiomers of prothrombin synthesis, protein carboxylation, and the regeneration of vitamin K from vitamin K epoxide. , 1981, Biochemical pharmacology.

[21]  A. Breckenridge,et al.  Kinetics of warfarin absorption in man , 1973, Clinical pharmacology and therapeutics.

[22]  T. Theofanous,et al.  Multiple-dose kinetics of oral anticoagulants: methods of analysis and optimized dosing. , 1973, Journal of pharmaceutical sciences.

[23]  L B Sheiner,et al.  Computer-aided long-term anticoagulation therapy. , 1969, Computers and biomedical research, an international journal.

[24]  William J. Jusko,et al.  Berichten , 2005, Pharmaceutisch weekblad.

[25]  L. Aarons,et al.  A comparison of the relative sensitivities of factor VII and prothrombin time measurements in detecting drug interactions with warfarin , 2004, European Journal of Clinical Pharmacology.

[26]  D. Mungall,et al.  Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation. , 1985, Therapeutic drug monitoring.